Publicaciones en las que colabora con Ihab Abdulkader Nallib (9)

2024

  1. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)

    Oncology reports, Vol. 52, Núm. 3

2023

  1. Occupation as a risk factor of small cell lung cancer

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

    Scientific Reports, Vol. 12, Núm. 1

  2. Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

    Frontiers in Endocrinology, Vol. 13

2021

  1. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study

    Oncology Letters, Vol. 22, Núm. 1

2017

  1. Assessment of HER2 status in resected gastric cancer in European population

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, pp. iii15

2009

  1. La expresión inmunohistoquímica intensa de ciclooxigenasa 2 se asocia inversamente con los valores máximos de SUV en la 18F-FDG-PET de pacientes afectados de carcinomas no microcíticos de pulmón. Relación con otros factores biológicos

    Revista española de medicina nuclear, Vol. 28, Núm. 1, pp. 11-14

  2. The immunohistochemical expression of cyclooxygenasa 2 is inversely associated with 18F-FDG-PET SUV values in non-small cell lung cancers. Initial results

    Revista Espanola de Medicina Nuclear, Vol. 28, Núm. 1, pp. 11-14

2007

  1. Tumoración en la encía en un paciente con antecedentes de cirrosis hepática

    Revista Clinica Espanola, Vol. 207, Núm. 7, pp. 365-366